Published in JAMA on July 26, 2006
Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med (2010) 8.70
Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia (2010) 2.20
Getting heavier, younger: trajectories of obesity over the life course. Int J Obes (Lond) (2009) 2.09
Dyslipidemia in youth with diabetes: to treat or not to treat? J Pediatr (2008) 1.72
High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care (2012) 1.64
Trends in the Diabetes Epidemic in Korea. Endocrinol Metab (Seoul) (2015) 1.25
Pediatric obesity: etiology and treatment. Endocrinol Metab Clin North Am (2009) 1.22
Type 2 translational research for CKD. Clin J Am Soc Nephrol (2013) 1.21
Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). Clin J Am Soc Nephrol (2011) 1.13
Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. Diabetes (2013) 1.11
Microalbuminuria: causes and implications. Pediatr Nephrol (2011) 1.05
Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics (2008) 1.04
Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr (2010) 0.94
Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians. Curr Diab Rep (2008) 0.92
Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis. CMAJ (2013) 0.92
Diabetic nephropathy in children and adolescents. Pediatr Nephrol (2007) 0.92
Treatment of type 2 diabetes in youth. Diabetes Care (2011) 0.91
Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis (2014) 0.91
Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study. BMC Nephrol (2012) 0.89
Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program. Am J Nephrol (2008) 0.88
Predictive value of albuminuria in American Indian youth with or without type 2 diabetes. Pediatrics (2010) 0.88
Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes. Diabetes Care (2009) 0.86
Diabetes and chronic kidney disease: lessons from the Pima Indians. Pediatr Nephrol (2008) 0.86
Diabetes, sugar-coated but harmful to the brain. Curr Opin Pharmacol (2007) 0.85
Independent and combined association of muscle strength and cardiorespiratory fitness in youth with insulin resistance and β-cell function in young adulthood: the European Youth Heart Study. Diabetes Care (2013) 0.85
Microvascular disease in children and adolescents with type 1 diabetes and obesity. Pediatr Nephrol (2010) 0.85
Regional differences in dialysis care and mortality among American Indians and Alaska Natives. J Am Soc Nephrol (2011) 0.85
The impact of disadvantage on the development and progression of diabetic kidney disease. Clin Nephrol (2010) 0.83
Impact of lifestyle modification on glycemic control in patients with type 2 diabetes mellitus. Indian J Endocrinol Metab (2013) 0.82
Pediatric obesity. An introduction. Appetite (2015) 0.81
Lifestyle therapy for the treatment of youth with type 2 diabetes. Curr Diab Rep (2015) 0.80
Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. BMC Pediatr (2012) 0.80
Genetics of cardiovascular and renal complications in diabetes. J Diabetes Investig (2015) 0.80
Relation between the level of American Indian and Alaska Native diabetes education program services and quality-of-care indicators. Am J Public Health (2008) 0.80
Nephropathy in youth and young adults with type 2 diabetes. Curr Diab Rep (2014) 0.79
The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study. Am J Med (2009) 0.79
Mortality experience of a low-income population with young-onset diabetes. Diabetes Care (2012) 0.79
Diabetic kidney disease in children and adolescents. Pediatr Nephrol (2014) 0.78
Kidney disease and youth onset type 2 diabetes: considerations for the general practitioner. Int J Pediatr (2012) 0.78
Pediatric obesity: etiology and treatment. Pediatr Clin North Am (2011) 0.78
In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: A systematic review. BMC Pediatr (2010) 0.77
Waist-to-height ratio as a screening tool for obesity and cardiometabolic risk. Korean J Pediatr (2016) 0.76
Changing course of diabetic nephropathy in the Pima Indians. Diabetes Res Clin Pract (2008) 0.76
Temporal Trends in the Epidemiology of Biopsy-Proven Glomerular Diseases: An Alarming Increase in Diabetic Glomerulosclerosis. Clin J Am Soc Nephrol (2017) 0.75
Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol (2015) 0.75
Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications. Nutrients (2017) 0.75
Long-term Effect of Losartan on Kidney Disease in American Indians With Type 2 Diabetes: A Follow-up Analysis of a Randomized Clinical Trial. Diabetes Care (2016) 0.75
Kidney disease in childhood-onset diabetes. Am J Kidney Dis (2008) 0.75
Bidirectional association between ESRD dialysis and diabetes: National cohort study. PLoS One (2017) 0.75
Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients. Chin Med J (Engl) (2016) 0.75
Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes. Diabetes Care (2016) 0.75
Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014. PLoS One (2017) 0.75
Resting Heart Rate Variability, Inflammation, and Insulin Resistance in Overweight and Obese Adolescents. Metab Syndr Relat Disord (2016) 0.75
Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years. J Am Heart Assoc (2017) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet (2008) 9.03
Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med (2010) 8.70
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care (2011) 5.50
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr (2011) 4.60
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab (2008) 4.29
The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials (2002) 4.03
Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (2002) 3.68
Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62
Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol (2005) 3.48
A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping. Am J Hum Genet (2007) 3.39
Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes (2002) 3.14
Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int (2012) 2.97
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest (2011) 2.90
A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes (2007) 2.67
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care (2007) 2.42
Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet (2002) 2.29
Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians. Hum Genet (2003) 2.27
The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27
Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes (2006) 2.21
Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes (2011) 2.17
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes (2008) 2.07
Childhood predictors of young-onset type 2 diabetes. Diabetes (2007) 2.06
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care (2003) 2.05
Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes (2010) 2.02
Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care (2006) 1.96
Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care (2007) 1.92
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care (2011) 1.78
Stabilization of glucose in blood samples: why it matters. Clin Chem (2009) 1.72
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes (2008) 1.71
Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care (2005) 1.70
Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity (Silver Spring) (2010) 1.64
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61
A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans. Hum Mol Genet (2010) 1.60
Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes (2007) 1.58
Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care (2007) 1.55
Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol (2003) 1.52
Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes (2007) 1.51
Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes (2007) 1.51
Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus. Diabetes Care (2013) 1.49
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab (2007) 1.49
Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care (2009) 1.48
Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes (2008) 1.48
Periodontal disease and mortality in type 2 diabetes. Diabetes Care (2005) 1.48
Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care (2003) 1.46
Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care (2003) 1.44
Testing for microalbuminuria in 2002: barriers to implementing current guidelines. Am J Kidney Dis (2003) 1.43
Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. Am J Kidney Dis (2008) 1.39
Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes (2012) 1.39
Stability of body weight in type 2 diabetes: Response to Chaudhry et al. Diabetes Care (2006) 1.39
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD. Circ Cardiovasc Genet (2015) 1.38
The 24-h carbohydrate oxidation rate in a human respiratory chamber predicts ad libitum food intake. Am J Clin Nutr (2007) 1.37
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes (2005) 1.34
Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab (2004) 1.34
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes (2011) 1.32
Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care (2007) 1.32
The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet (2003) 1.31